Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01641913 · ClinicalTrials.gov registry record · Phase 1

Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients

A Phase 1 study, sponsored by Mayo Clinic.

Completed
Registry status
Phase 1
Development phase
20
Enrollment target

NCT01641913: Completed Phase 1 study, sponsored by Mayo Clinic.

NCT01641913 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01641913, a Phase 1 study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 1
Development phase
20 participants
Enrollment target

Study Summary

Do patient's with eosinophilic esophagitis have increased small intestinal permeability and if this changes in response to topically administered esophageal steroids?

Primary Outcome

heartburn, trouble swallowing

Interventions

  • OTHER Absorbable sugars

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2012-08
Est. Completion 2014-02
Phase Phase 1
Mayo Clinic

2,844 total trials

What the finished NCT01641913 record still lists

NCT01641913 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).

The record links to 0 conditions, and to 1 intervention - of which Absorbable sugars is the first listed.

NCT01641913 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01641913 about?

NCT01641913 is a clinical study titled "Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients". Do patient's with eosinophilic esophagitis have increased small intestinal permeability and if this changes in response to topically administered esophageal steroids?

What is the current status of trial NCT01641913?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2012-08. Estimated completion is 2014-02.

What interventions are being tested in trial NCT01641913?

The interventions under investigation include: Absorbable sugars (OTHER).

Who is sponsoring clinical trial NCT01641913?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01641913's enrollment target sits among peer trials

20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01641913, the US trial registry maintained by the National Library of Medicine. NCT01641913 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.